Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA)

Q: What does CUSIP 92337R101 represent in this 13F holders report?

CUSIP 92337R101 is the security identifier for VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share in Q4 2023?

93 institutional investors reported VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share for Q4 2023. Use the holders table for investor-level position and value details.

CUSIP: 92337R101

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class: Equity / Class A Common Stock, par value $0.001 per share
Shares outstanding: 72,325,000
Total 13F shares: 41,345,437
Share change: +2,843,017
Total reported value: $635,880,813
Put/Call ratio: 487%
Price per share: $15.38
Number of holders: 93
Value change: +$44,778,975
Number of buys: 51
Number of sells: 31

Quarterly Holders Quick Answers

What is CUSIP 92337R101?
CUSIP 92337R101 identifies VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2024
Previous quarter: Q3 2023

Recent filing periods for CUSIP 92337R101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Commodore Capital LP	13F	Company	7.5%	5,450,000	$74,719,500	—	30 Sep 2023	13F
FMR LLC	13F	Company	7.5%	5,445,366	$74,655,967	—	30 Sep 2023	13F
Sofinnova Venture Partners X, L.P.	3/4/5	10%+ Owner	— class O/S missing	3,467,156	$62,408,808	—	06 Feb 2023	3/4/5
Emster Kurt von	3/4/5	Director	— mixed-class rows	2,987,984 mixed-class rows	$53,605,062	—	17 May 2021	3/4/5
Abingworth LLP	3/4/5	10%+ Owner	— mixed-class rows	2,970,156 mixed-class rows	$53,284,158	—	13 May 2021	3/4/5
Carlyle Group Inc.	3/4/5 13F	10%+ Owner · Company	2% from 13F	2,960,231	$53,284,158	—	17 Aug 2022	3/4/5 13F
Sofinnova Investments, Inc.	13F	Company	4.8%	3,467,156	$47,534,709	—	30 Sep 2023	13F
Kynam Capital Management, LP	13F	Company	4.1%	2,956,053	$40,527,487	—	30 Sep 2023	13F
Woodline Partners LP	13F	Company	3.5%	2,562,600	$35,133,246	—	30 Sep 2023	13F
BlackRock Finance, Inc.	13F	Company	3.3%	2,358,418	$32,333,911	—	30 Sep 2023	13F
Longitude Capital Partners IV, LLC	3/4/5	10%+ Owner	— class O/S missing	1,714,285	$30,857,130	—	06 Feb 2023	3/4/5
Longitude Prime Partners, LLC	3/4/5	10%+ Owner	— class O/S missing	1,714,285	$30,857,130	—	06 Feb 2023	3/4/5
STATE STREET CORP	13F	Company	2.4%	1,727,646	$23,686,027	—	30 Sep 2023	13F
VANGUARD GROUP INC	13F	Company	2.2%	1,574,390	$21,584,887	—	30 Sep 2023	13F
ORBIMED ADVISORS LLC	13F	Company	2.1%	1,518,115	$20,813,357	—	30 Sep 2023	13F
Eversept Partners, LP	13F	Company	2%	1,478,489	$20,270,084	—	30 Sep 2023	13F
Pictet Asset Management Holding SA	13F	Company	1.7%	1,226,147	$16,810,475	—	30 Sep 2023	13F
MORGAN STANLEY	13F	Company	1.3%	914,746	$12,541,168	—	30 Sep 2023	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	1%	758,355	$10,381,880	—	30 Sep 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1%	738,567	$10,127,020	—	30 Sep 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.58%	419,804	$5,755,513	—	30 Sep 2023	13F
Invesco Ltd.	13F	Company	0.54%	390,781	$5,357,608	—	30 Sep 2023	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.49%	357,139	$4,896,376	—	30 Sep 2023	13F
Altium Capital Management LLC	13F	Company	0.46%	333,681	$4,574,767	—	30 Sep 2023	13F
Alphabet Inc.	13F	Company	0.42%	301,580	$4,134,661	—	30 Sep 2023	13F
NORTHERN TRUST CORP	13F	Company	0.41%	295,504	$4,051,359	—	30 Sep 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.4%	290,898	$3,988,212	—	30 Sep 2023	13F
AXA S.A.	13F	Company	0.37%	270,993	$3,715,314	—	30 Sep 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.37%	267,004	$3,660,625	—	30 Sep 2023	13F
PLATINUM INVESTMENT MANAGEMENT LTD	13F	Company	0.28%	200,302	$2,746,140	—	30 Sep 2023	13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)	13F	Company	0.25%	177,991	$2,440,257	—	30 Sep 2023	13F
D. E. Shaw & Co., Inc.	13F	Company	0.22%	158,186	$2,168,730	—	30 Sep 2023	13F
Rafferty Asset Management, LLC	13F	Company	0.19%	136,377	$1,869,729	—	30 Sep 2023	13F
Polar Asset Management Partners Inc.	13F	Company	0.19%	135,755	$1,861,201	—	30 Sep 2023	13F
Bank of New York Mellon Corp	13F	Company	0.18%	128,232	$1,758,060	—	30 Sep 2023	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.15%	105,000	$1,439,550	—	30 Sep 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.14%	100,561	$1,378,691	—	30 Sep 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.13%	95,116	$1,304,041	—	30 Sep 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.12%	87,200	$1,196,000	—	30 Sep 2023	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.12%	84,506	$1,158,578	—	30 Sep 2023	13F
JANE STREET GROUP, LLC	13F	Company	0.11%	83,025	$1,138,273	—	30 Sep 2023	13F
BARCLAYS PLC	13F	Company	0.1%	71,703	$983,048	—	30 Sep 2023	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.1%	69,671	$955,189	—	30 Sep 2023	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.09%	68,306	$936,475	—	30 Sep 2023	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.09%	62,322	$854,435	—	30 Sep 2023	13F
CITIGROUP INC	13F	Company	0.08%	57,390	$786,817	—	30 Sep 2023	13F
Swiss National Bank	13F	Company	0.07%	48,700	$667,677	—	30 Sep 2023	13F
RHUMBLINE ADVISERS	13F	Company	0.07%	48,411	$663,700	—	30 Sep 2023	13F
Crestline Management, LP	13F	Company	0.06%	45,380	$622,160	—	30 Sep 2023	13F
Weiss Multi-Strategy Advisers LLC	13F	Company	0.06%	45,192	$620,000	—	30 Sep 2023	13F

Institutional Holders of Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA) as of Q4 2023

As of 31 Dec 2023, Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA) was held by 93 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 41,345,437 shares. The largest 10 holders included COMMODORE CAPITAL LP, Kynam Capital Management, LP, Sofinnova Investments, Inc., FMR LLC, BlackRock Inc., Woodline Partners LP, STATE STREET CORP, Eversept Partners, LP, VANGUARD GROUP INC, and ORBIMED ADVISORS LLC. This page lists 93 institutional shareholders reporting positions in this security for the Q4 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders

Q4 2023 holders

Holder diff

Investor	Q3 2023 Shares	Q4 2023 Shares	Share Diff	Share Chg %	Q3 2023 Value $	Q4 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.